TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975
TCL Archive Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage. July 12, 1991
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down November 22, 2002
